O N C O L O G Y

O n c o l o g y
G l o b a l

Helping people lead

Oncology
Dr. Reddy's Laboratories Ltd.,
Greenlands, Ameerpet, Hyderabad 500 016, India.
Visit us: www.drreddys.com
healthier lives
L I F E . R E S E A R C H . H O P E L I F E . R E S E A R C H . H O P E
 Where there's a will,

there's life
Dr. Reddy's Laboratories Ltd. is a global pharmaceutical company, making

high quality medicines accessible to patients worldwide. The Global

Oncology Division is excited about the giant strides in cancer care and is

committed to satisfying unmet medical needs of cancer patients.

Our Oncology products are available in 25 countries and have touched

the lives of millions of patients.

Dr. Reddy's: Facts in the life of a

trusted healthcare company
NYSE listed pharmaceutical company with $ 1.5 billion FY07 revenue

Revenue growth of 35% CAGR from FY01 - FY06

Global commercialization presence in North America, Germany, India,

Russia, UK, South Africa, Brazil, China, Spain, Australia, New Zealand...

Fully integrated product development

Consistent winner at Pharma Excellence Awards every year

Strong corporate governance: Sox certified company;

SAFA award for best financial reporting
 The strides made in Oncology have increased the life expectancy of

millions of patients. Dr. Reddy's Oncology is geared to support the

community of Oncologists with our novel drugs, diverse portfolio,

state-of-the-art facilities, team of dedicated professionals, and our

worldwide network and presence. Products are fast tracked from bench to

bedside at our Integrated Product Development Organization. Thus, we

are fully prepared to offer the best options to Oncologists and their

patients. Consider the following advantages:

Equipped to fight ● Global commercialization presence in US, Europe, India, Russia,

to save lives
South Africa & Brazil

● Strong Biologics & Cytotoxic infrastructure to address

Oncology market

● Robust portfolio of targeted therapies, cytotoxics,

anti-hormonals and supportive care

● Capability to swiftly register & launch new products globally

● Dedicated Oncology team

● ANVISA approved Biologics facilities

 Professionals who give life At Dr. Reddy's, we aim to help people lead healthier lives through two parallel objectives: delivering affordable

and accessible medication to all parts of the world; and discovering, developing and commercializing

their best shot

innovative medicines that satisfy unmet medical needs in cancer. Quality, social responsibility, mutual respect,

teamwork, and innovation are part of our values that drive us to achieve our objectives. These guide our

entrepreneurial thoughts and global actions and inspire us in our fight against cancer. We imbibe global

best-practices for developing patent-free Oncology products and successful track record of partnerships, both

For Dr. Reddy's team of scientists, technicians, product managers, medical representatives and a host of support of which contribute to sharing the social and financial burden of healthcare systems. This forms the basis for the

personnel, Oncology is their life’s work. Their professional approach is matched by their personal commitment. trust placed in us by people all over the world.

The products and services they deliver and the respect of the medical community they have earned vouch for
G V Prasad
their dedication to improved cancer care. It also accounts for the company's standing as one of the most trusted Vice-Chairman & CEO

names in Oncology.
Quest for more

efficacious
and affordable
therapy
Every human deserves a chance at life. Dr. Reddy's endeavour is multi-faceted. On the

one hand it is to make treatment affordable and accessible to all sections of society.

On the other, it is to make the highest quality medicines, with minimal side effects.

The Oncology pipeline holds great hope for the future.

Oncology Pipeline
Cytotoxic Drugs Targeted Anti-Hormonal Supportive
Therapies Therapies Care

Gemcitabine (Cytogem) Filgrastim

Pemetrexate (Pemgem) (Grafeel)
Capecitabine (Capiibine) Zolendronic Acid
Rituximab Letrozole (Blaztere)
Thalidomide (Thaangio) (Reditux) (Oreta)
Lenalidomide (Lenangio) Pamidronate
(Pamired)
Irnotecan (Irnocam)
Palnosetron
Topotecan (Cantop) (Palzen)
Paclitaxel (Mitotax)
Ondansetron
Docetaxel (Docetere) (Onset)
Lomustine (Lomtin)

4 new 10 new 5 new 5 new

products products products products
Global brands: Infrastructure:
hope has many names
The progress made in the field of Oncology has resulted in optimal clinical outcomes. Dr. Reddy's has a robust

portfolio of targeted therapies, cytotoxics, anti-harmonals and supportive care that Oncologists can rely on to
depth and width
ensure a better quality of life for their patients.
● Europe & WHO approved state-of-the-art Oncology facilities for
development, clinical and commercialization

● Cytotoxic & anti-hormonal manufacturing oral

solid dosage capabilities (tablets & capsules)

● Aseptic capabilities (liquid and lyophilized vials)

● Currently available
- e. coli GMP manufacturing
- Mammalian cell culture GMP manufacturing
Capecitabine 250, 500 mg Tablets - Filling line for vials/PFS
- cGLP R&D centre including pre-clinical study center

● Ongoing construction/commission
- Large scale mammalian cell culture GMP manufacturing
- Lyophilizer

Pamidronate Disodium Injection 30 mg / 60 mg

For the use of Registered Medical Practitioners / Hospitals / Laboratories only

A potent IMiD
Efficacy + More
 Corporate social

responsibility
At Dr. Reddy’s, we help people lead healthier lives. We recognize the

importance and impact our Oncology products can have on people’s lives.

Inline with our vision, we seek to increase access to medicines and raise

disease awareness in society. Our ‘Patient Assistance Program’ and

‘Awareness for life’ program have been novel initiatives in this direction.

● Patient Assistance Program empowers doctors to identify needy

patients and offer them anti-cancer medicines free of cost. Thousands

of patients have already benefitted through this program.

● ’Awareness for life’ is an initiative to create cancer awareness in society.

We have a dedicated team and state-of-the-art facilities to conduct

such programs and cancer screening camps in rural India.

 Global
Scientific presence
Updates
Continuing Medical Education programs and symposiums with
international faculty, journal updates and other promotions are
conducted on a regular basis.

Headquarters

Wholly Owned Subsidiaries

Representative Offices

Global Acquisitions

Manufacturing Locations

Joint Ventures

Research Locations

Achievements &
Sustainability report, accolades
a first Ameristar Award
(Mitotax) Worldstar and
Indiastar Packaging
Awards 2007

Dr. Reddy's is India's first healthcare product

company (out of 823 companies worldwide

Pharma Excellence
that publish sustainability reports) to be on the Award 2006-07

Global Reporting Initiatives list of the United

Nations environmental programs.

Billicare Award NDTV Business
(Grafeel) Leadership Award 2007
 You are Dr. Reddy's Global Oncology has forged long lasting partnerships with Oncologists, hospitals and

invaluable
teaching institutes. We are trusted for our products & commitment and seek more partnerships.

To begin a relationship, contact us at:

e-mail: oncology@drreddys.com

Contact:
United States of America United Kingdom
Dr. Reddy's Laboratories Inc. Dr. Reddy's Laboratories (UK) Limited
200 Somerset Corporate Blvd, Building II, 258 Bath Road, Slough, Berkshire SL1 4DX
7th Floor, Bridgewater, NJ 08807 Tel: 0044 1753 5125 00, Fax: 0044 1753 6966 77
Tel: 908 203 4900, Fax: 908 203 4970
Switzerland
Germany Dr. Reddy's Laboratories Ltd.
betapharm Arzneimittel GmbH St. Jakobs-strasse 30, CH 4052 Basel
Kobelweg 95, 86156 Augsburg Tel: +41 61 271 4754, Fax: + 41 61 271 4755
Tel: 0049 821 748810, Fax: 0049 821 74881420
Russia
India 143422, Moscow region, Krasnogorsk Distt.,
Dr. Reddy's Laboratories Ltd. MO Petrovo Dalneye
7-1-27, Ameerpet, Hyderabad 500 016, India Tel / Fax: 007 095 4184822
Tel: +91 40 23731946, Fax: +91 40 23731955
Romania
Brazil Dr. Reddy's Laboratories Ltd.
Dr. Reddy's Farmaceutica do Brasil Ltd. Str. AV Petre Cretu Nr 74, Apt. 2,
AV. Guido caloi, 1985, Galpao 11, Sector 1, Bucharest 71328
JD. Sao Luiz 05802 - 140, Sao Paulo, Brazil Tel: 0040 21 2240032, Fax: 0040 21 2241877
Tel: 0055 11 5515 8100, Fax: 0055 11 5515 8113
Mexico
China Dr. Reddy's de Mexico
Kunshan Rotam Reddy Pharma Co. Ltd. Km 4.5 Carr. Fed. Cuernavaca-Cuautla,
No. 258, Huang Pu Jiang Zhong Road, 62578, CIVAC Jiutepec Morelos
Kunshan, Jiangsu, PRChina, Tel: +52 777 329 3450, Fax: +52 777 320 2754
PC:215300, People's Republic of China
Tel: 0086 512 5770 2217, 021 631 79080, Vietnam
512 577 09164, 512 577 07030, Fax: 0086 512 5771 1634 Dr Reddy's Laboratories Ltd.
51 - 53 K M Plaza, 3rd Floor,
Singapore Vo Van Tan Street, Dist. 3,
Reddy Pharmaceuticals Singapore Pte Ltd. Hochiminh City, Vietnam
400 Orchard Road, #11-11 Orchard Towers, Tel: 0084 8 9300502 / 03, Fax: 0084 8 9300504
Singapore 238875
Tel: 0065 734 2010, Fax: 0096 734 0376 Venezuela
Dr. Reddy's Laboratories Ltd.
Malaysia Av. Rio Caura, Torre Humbold, Piso 11,
Diong Sing Peng Ofic. 1107, piso 15,oficina 1501.
M/S Pahang Pharmacy Sdn Bhd., Prados del Este., Caracas D.C. 1080,
Lot 5979 Jalan Teratai 5 1/2 Miles Off Jalan Meru, Venezuela
41050, Klang, Selangor Darul Ehsan, Malaysia Tel: 0058 212 9766452, 9752855, 9764377,
Tel: 00 603 7880 9318, Tel: 00 603 3393 1978 Fax: 0058 212 9751135

Sri Lanka Mauritius

Dr. Reddy's Laboratories Ltd. Symbiotic Ltd.
15, Tichbourne Passage, G.P.O. Box No.490, Rossun Road,
Colombo 10, Sri Lanka Pailles, Port Louis, Mauritius
Tel: 0094 11 2676 436, 2694 864 / 865, Tel: 00230 211 2656/7,
Fax: 0094 11 2672 652 Fax: 00230 211 2658, 00233 21 668094

Back cover: Innovation Plaza is a unique, one of its kind facility created to house the Integrated Product Development Organization of Dr. Reddy's.
Spacious, naturally lit laboratories overlooking lush greenery have scientists working on innovative processes for product development, while the
analytical minds of the Intellectual Property Management teams tick away with creative ideas.